| Stage | APT | % of rev | ISRG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $19M | 100.00% | $3.0B | 100.00% | ISRG ×163.26 |
| Gross profit | $7M | 37.37% | $2.1B | 68.37% | ISRG +31.0pp |
| Operating income | $2M | 10.77% | $593M | 19.44% | ISRG +8.7pp |
| Pre-tax income | $2M | 12.77% | $668M | 21.92% | ISRG +9.2pp |
| Net income | $2M | 9.78% | $524M | 17.20% | ISRG +7.4pp |
| Stage | APT | ISRG | Gap · A − B |
|---|---|---|---|
| Revenue | $19M100.00% | $3.0B100.00% | ISRG ×163.26 |
| Gross profit | 37.37%$7M | 68.37%$2.1B | ISRG +31.0pp |
| Operating income | 10.77%$2M | 19.44%$593M | ISRG +8.7pp |
| Pre-tax income | 12.77%$2M | 21.92%$668M | ISRG +9.2pp |
| Net income |
| 9.78%$2M |
| 17.20%$524M |
| ISRG +7.4pp |
No shared counterparties.